--2025/Q1-- / 2.450M--
--2024/Q4-- / 4.200M--
--2024/Q34.894M / 3.600M--
--2024/Q24.831M / 3.256M--
--2024/Q14.216M / 3.214M--
MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
STOK Stoke Therapeutics
- 11.680
- +0.380+3.36%
Close Dec 20 16:00 ET
- 11.680
- 0.0000.00%
Post 20:01 ET
618.65MMarket Cap-5.62P/E (TTM)
11.840High10.810Low1.18MVolume10.810Open11.300Pre Close13.73MTurnover3.22%Turnover RatioLossP/E (Static)52.97MShares17.58052wk High2.67P/B429.29MFloat Cap4.09052wk Low--Dividend TTM36.75MShs Float71.580Historical High--Div YieldTTM9.12%Amplitude3.350Historical Low11.604Avg Price1Lot Size
Stoke Therapeutics Key Stats
Stoke Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Stoke Therapeutics Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data